Tobam Has $298,000 Stock Position in Agilent Technologies, Inc. (NYSE:A)

Tobam grew its holdings in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 14.7% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,047 shares of the medical research company’s stock after buying an additional 262 shares during the period. Tobam’s holdings in Agilent Technologies were worth $298,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of A. Vanguard Group Inc. grew its stake in Agilent Technologies by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 25,279,117 shares of the medical research company’s stock valued at $3,514,556,000 after acquiring an additional 206,865 shares during the period. Massachusetts Financial Services Co. MA grew its position in Agilent Technologies by 19.6% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 13,246,489 shares of the medical research company’s stock valued at $1,841,659,000 after purchasing an additional 2,170,219 shares during the period. Wellington Management Group LLP increased its stake in Agilent Technologies by 17.4% during the 3rd quarter. Wellington Management Group LLP now owns 10,255,526 shares of the medical research company’s stock valued at $1,146,773,000 after purchasing an additional 1,519,134 shares in the last quarter. Norges Bank acquired a new position in Agilent Technologies during the fourth quarter worth $509,904,000. Finally, Van ECK Associates Corp lifted its stake in shares of Agilent Technologies by 0.9% in the first quarter. Van ECK Associates Corp now owns 2,774,984 shares of the medical research company’s stock valued at $403,788,000 after buying an additional 25,127 shares in the last quarter.

Wall Street Analysts Forecast Growth

A has been the subject of a number of analyst reports. JPMorgan Chase & Co. lowered their price target on Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. Bank of America boosted their price target on shares of Agilent Technologies from $134.00 to $140.00 and gave the stock a “neutral” rating in a report on Tuesday, June 25th. Jefferies Financial Group reiterated a “hold” rating and issued a $135.00 price objective (down previously from $152.00) on shares of Agilent Technologies in a research note on Monday, June 3rd. Stifel Nicolaus dropped their price target on Agilent Technologies from $163.00 to $151.00 and set a “buy” rating on the stock in a report on Thursday, May 30th. Finally, Wolfe Research cut shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $137.13.

Check Out Our Latest Analysis on Agilent Technologies

Agilent Technologies Trading Down 0.6 %

NYSE:A traded down $0.78 during trading hours on Monday, reaching $125.59. The company’s stock had a trading volume of 122,821 shares, compared to its average volume of 1,775,564. The firm has a 50-day simple moving average of $138.51 and a 200-day simple moving average of $138.09. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.64 and a current ratio of 2.15. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $155.35. The firm has a market capitalization of $36.64 billion, a price-to-earnings ratio of 29.87, a PEG ratio of 4.29 and a beta of 1.05.

Agilent Technologies (NYSE:AGet Free Report) last announced its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.03. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. The firm had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the previous year, the company posted $1.27 earnings per share. The business’s revenue was down 8.4% on a year-over-year basis. Research analysts expect that Agilent Technologies, Inc. will post 5.25 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be issued a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.75%. The ex-dividend date of this dividend is Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.22%.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $130.00, for a total transaction of $254,540.00. Following the transaction, the chief executive officer now owns 25,185 shares in the company, valued at $3,274,050. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total transaction of $254,540.00. Following the completion of the transaction, the chief executive officer now owns 25,185 shares in the company, valued at $3,274,050. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the transaction, the senior vice president now directly owns 49,486 shares of the company’s stock, valued at approximately $6,595,494.08. The disclosure for this sale can be found here.

About Agilent Technologies

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Recommended Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.